CD34 and hepatocellular carcinoma: Particularly noteworthy, MVD rates estimated by CD34 were significantly higher in C. sinensis (+) HCC patients than in C. sinensis (-) HCC patients (64.13% vs 52.98%, p = 0.041, Fig 3A).